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Background: Mechanical ventilation (MV) induces an inflamma-
tory response that may result in (acute) lung injury. Lidocaine, an
amide local anesthetic, has anti-inflammatory properties in vitro and
in vivo, possibly due to an attenuation of pro-inflammatory cyto-
kines, intracellular adhesion molecule-1 (ICAM-1), and reduction of
neutrophils influx. We hypothesized an attenuation of MV-induced
inflammatory response with intravenously administered lidocaine.
Methods: Lidocaine (Lido) (2, 4, and 8 mg/kg/h) was intrave-
nously administered during 4 h of MV with a tidal volume of 8 ml/
kg, positive end expiratory pressure 1,5 cmH2O and FiO2 0.4. We
used one ventilated control (CON) group receiving vehicle. After
MV, mice were euthanized, and lungs and blood were immediately
harvested, and cytokine levels and ICAM-1 levels were measured in
plasma and lung homogenates. Pulmonary neutrophils influx was
determined in LEDER-stained slices of lungs. Anesthetic need was
determined by painful hind paw stimulation.
Results: Lidocaine-treated animals (Lido 2, 4 and 8 mg/kg/h)
showed higher interleukin (IL)-10 plasma levels compared to
control animals. Lidocaine treatment with 8 mg/kg/h (Lido 8)
resulted in higher IL-10 in lung homogenates. No differences were
observed in pro-inflammatory cytokines, ICAM-1, and pulmonary
influx between the different ventilated groups.
Conclusions: Intravenously administered lidocaine increases
levels of plasma IL-10 with infusion from 2, 4, and 8 mg/kg/h and
pulmonary levels of IL-10 with 8 mg/kg/h in a murine mechanical
ventilation model. Intravenously administered lidocaine appears to
reduce anesthetic need in mice.
For patients with acute respiratory failure,
mechanical ventilation (MV) can be life saving.
However, a large body of evidence suggests that
MV can result in lung injury, so-called ventilator-
induced lung injury.1,2 It is widely assumed that
an inflammatory response, characterized by
release of inflammatory cytokines and influx of
immune cells such as neutrophils contributes to
the development of lung injury.2–4 To date, no
effective therapy exists to attenuate the
MV-induced inflammatory response.
Lidocaine is an amide local anesthetic and a
nonspecific sodium channel blocker that is mostly
used for the treatment of acute and chronic pain. It
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was demonstrated that low-dose intravenous
lidocaine acts as an anti-hyperalgesic and anti-
inflammatory agent.5,6 Extensive in vitro research
showed that lidocaine attenuates priming of
human neutrophils by inhibition of G-protein
coupled receptors.7,8 Furthermore, lidocaine
attenuated activated endothelial interleukin
(IL)-1, 6, and 8 concentrations and intracellular
adhesion molecule-1 (ICAM-1), important for
transport of immune cells to site of inflamma-
tion.9,10 In different in vivo models, intravenous
lidocaine reduced levels of tumor necrosis factor
(TNF)-α, IL-1β, IL-6, and Il-8.11–13 Also, systemic
lidocaine was found to attenuate acute lung injury
in rabbits.14,15 An additional effect of lidocaine
infusion is that the requirements for anesthetics
are diminished.16,17 In human research, an attenu-
ation in inflammatory response (measured by
IL-6, IL-8, and an IL-1 receptor antagonist) in
plasma has been found at the end of abdominal
surgery in response to lidocaine.18–20
Since lidocaine seems to have prominent anti-
inflammatory effects, we aim to investigate the
role of intravenously administered lidocaine at
different dosages of 2 mg/kg/h, 4 mg/kg/h, and
8 mg/kg/h during 4 h of mechanical ventilation in
healthy mice in an established acute phase
model.21–23
We hypothesize that intravenously adminis-
tered lidocaine attenuates the inflammatory
response following MV.
Methods
All experiments were approved by the Regional
Animal Ethics Committee in Nijmegen and per-
formed under the guidelines of the Dutch Council
for Animal Care and The National Institutes of
Health.
Animals
All studies were performed in C57BL6 male mice
in our established MV mice model.21–23 Mice were
housed in a light and temperature controlled
room under specific pathogen-free conditions.
Standard pelleted chow (1.00% Ca; 0.22% Mg;
0.24% Na; 0.70% P; 1.02% K; SSNIFF Spezi-
aldiäten GmbH, Soest, Germany) and drinking
water were available ad libitum.
Experimental design
Four groups of mice (n = 8/group, randomly allo-
cated) were studied after MV: control mice with
vehicle (CON) and three groups of mice treated
with different doses of lidocaine 2% (Lido) (Fre-
senius Kabi, Zeist, the Netherlands), 2 mg/kg/h
(Lido 2), 4 mg/kg/h (Lido 4), and 8 mg/kg/h
(Lido 8). Lidocaine was administered intrave-
nously via an indwelling intravenous tail catheter
just before MV and continued during 4 h. The
control group (CON) received an equal volume of
NaCl 0.9% intravenously. Intra-arterial carotid
blood pressure and heart rhythm was measured
throughout the experiment. Arterial blood gas
analysis (iSTAT, Abbott, Birmingham, United
Kingdom) was performed after 4 h of MV (data
not shown).
Lipopolysaccharide (LPS) was measured in
the ventilation circuit by Limulus Amebocyte
Lysate testing (Cambrex Bio Science, Walkers-
ville, MD; detection limit: 0.06 IU/ml) to rule
out contamination with LPS in our experimental
setting. No LPS could be detected in air, tubing,
or ventilator.
Mechanical ventilation and anesthetic need
Mice were anesthetized with an intraperitoneal
injection of a combination of ketamine, medeto-
midine, and atropine (KMA): 7.5 μl per gram of
body weight of induction KMAmix (consisting of
1.26 ml ketamine, 100 mg/ml; 0.2 ml medetomi-
dine, 1 mg/ml; 1 ml atropine, 0.5 mg/ml; and
5 ml NaCl, 0.9%). Animals were orally intubated
and mechanically ventilated (MiniVent, Hugo
Sachs Elektronik-Harvard apparatus, March-
Hugstetten, Germany) for 4 h. The following MV
settings were used: tidal volume 8 ml/kg and fre-
quency 170 / min, 1,5 cm H2O positive end-
expiratory pressure and fraction of inspired
oxygen was set to 0.4. These settings are within
the normal range of tidal volume, and respiratory
rate measured during spontaneous ventilation in
C57BL6 mice.24
To maintain anesthesia, 5.0 μl per gram of body
weight boluses of maintenance KMA mix (con-
sisting of 0.72 ml ketamine, 100 mg/ml; 0.08 ml
medetomidine, 1 mg/ml; 0.3 ml atropine, 0.5 mg/
ml; and 18.9 ml NaCl, 0.9%) was administered
when showed a positive reaction after manually
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administered painful hind paw stimulation via an
intraperitoneally placed catheter. Painful hind
paw stimulation was performed every 30 min and
represented anesthetic need. Rectal temperature
was monitored continuously and maintained
between 36.0°C and 37.5°C using a heating pad.
Tissue harvesting
Blood was collected by exsanguination, centri-
fuged (5 min, 14,000 rpm), and plasmawas stored
at −80°C for cytokine analysis. Immediately after
exsanguination, heart and lungs were carefully
removed en block via midline sternotomy. The
right upper and lower lobes were snap frozen in
liquid nitrogen and stored at −80°C. The left lobes
were snap frozen and placed in 500 μl lysis buffer
containing phosphate buffered saline, 0.5% triton
X-100, and protease inhibitor (complete EDTA-
free tablets, Roche, Woerden, the Netherlands).
Subsequently, the left lobes were homogenized
using a polytron and subjected to two rapid freeze-
thaw cycles using liquid nitrogen. Finally, homog-
enates were centrifuged (10 min, 14,000 r.p.m.,
4°C), and the supernatant was stored at −80°C
until cytokine analysis.
Cytokine analysis
A simultaneous Luminex assay was used to deter-
mine plasma cytokine levels of TNF-α, IL-6,
IL-10, keratinocyte-derived chemokine (KC), and
IL-1β (Milliplex, Millipore, Billerica, MA, USA).
TNF-α, IL-6, and KC (murine equivalent of
human IL-8) in lung homogenate were deter-
mined by enzyme-linked-immunosorbent assay
(ELISA) (for IL-6 and IL10; CytoSet, BioSource,
CA, USA; for TNF-α and KC; ELISA-Kit, R&D
Systems, Minneapolis, MN, USA). Lower detec-
tion limits: IL-1α and IL-1β 40 pg/ml; TNF-α:
32 pg/ml; IL-6: 160 pg/ml; IL-10: 16 pg/ml and
KC: 160 pg/ml.
IL-1β and IL-1α in lung homogenate were
determined using a radioimmunoassay as
described previously.23 Total protein concentra-
tions in the lung homogenates were determined
using a bicinchoninic acid assay (Thermo Fisher
Scientific, Etten-Leur, the Netherlands). Cytokine
concentrations in the homogenates were normal-
ized for protein concentration.
ICAM-1 analysis
Concentration of mouse sICAM-1 was deter-
mined in plasma and lung tissue using the quan-
tikine mouse sICAM (CD54) ELISA (MIC100) kit
(R & D systems, Abingdon, United Kingdom).
Lower detection limits: 24,8 ng/ml.
Pulmonary neutrophil influx
After overnight incubation in 4% buffered forma-
lin solution, the right middle lung lobe was dehy-
drated and embedded in paraplast (Amstelstad,
Amsterdam, the Netherlands). Sections of 4-μm
thickness were used. Enzyme histochemistry
using chloracetatesterase (LEDER staining) was
used to visualize the enzyme activity in the neu-
trophils. Neutrophils were counted manually (10
fields per mouse, blinded), and after automated
correction for air/tissue ratio, the average number
of neutrophils/μm2 per mouse was calculated.23
Statistical analysis
We performed a sample size calculation based on
previous investigations considering a difference
of 40% in cytokine levels between ventilated and
control mice with a type 1 error of 5% (α = 0.05)
and a power of 80% (β = 0.2).21–23 This resulted in
a group size of eight animals per group.
Shapiro–Wilk tests showed that data were not
normally or log normally distributed.
Data are therefore expressed as median with
interquartile range and depicted as column bar
graphs. Differences between controls vs. lido-
caine groups were studied using Mann–Whitney
tests. Statistical analysis was performed using
Graphpad Prism 5 software (Graphpad Software,
La Jolla, CA, USA). P-values < 0.05 were consid-
ered significant.
Results
Cardiopulmonary physiology
All mice in this experiment exhibited stable
hemodynamic variables during MV (P > 0.05).
Mean arterial pressure was within normal
limits and remained above 65 mmHg (except in
one mouse measured in the Lido 8 group), which
was in line with previous data from our lab in this
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model.21–23 We did not observe arrhythmic
changes in the different MV groups (except one
mouse measured in the Lido 8 group). Blood gas
values remained within normal range after 4 h of
MV, and no differences were observed within the
ventilated groups (data not shown). Four mice,
one in each group, died during the experiment
(n = 7 in each group remaining). Two mice died
during instrumentation (CON, Lido 2, no mea-
surement on hemodynamics obtained yet), one
mouse died in its cage before the experiment
started without apparent reason (Lido 4). One
mouse died before the end of the experiment
(Lido 8) from severe hypotension and bradycardia
resulting in death.
Cytokine analysis in plasma
Cytokine analysis in plasma revealed no signifi-
cant differences between the ventilated groups in
IL-1β, IL-6, TNF-α, and KC. However, IL-10
analysis showed a significant increase in all the
lidocaine groups, 2, 4, and 8 mg/kg/h (Lido 2,
Lido 4, and Lido 8) in comparison with the
control group (CON) (Fig. 1).
Cytokine analysis in lungs
IL-10 analysis showed a significant increase
between the control group (CON) in comparison
with the lidocaine 8 mg/kg/h group (Lido 8) but
not in comparison with the lidocaine 2 mg/kg/h
and 4 mg/kg/h group (Fig. 2).
Cytokine analysis in lung homogenates
revealed no significant differences between the
different ventilated groups in IL-1β, IL-6, TNF-α,
KC, and IL-1α.
ICAM-1 analysis
ICAM-1 analysis in plasma and lung homog-
enates showed no significant differences between
the different ventilated groups (Fig. 3).
Pulmonary neutrophil influx
No significant differences between pulmonary neu-
trophil influx measured per μm2 were observed
between the different ventilated groups (Fig. 4).
Anesthetic need
Mice showed a decrease in anesthetic need in
lidocaine 2 mg/kg/h and lidocaine 8 mg/kg/h
(lido 2 and 8) group, compared with control mice
(CON) (Fig. 5).
Discussion
This study is the first to show that intravenously
administered lidocaine caused an increase in
pulmonary and systemic IL-10 levels following
MV in healthy mice compared to control
animals.
IL-10 is a well-known anti-inflammatory cyto-
kine which limits the immune response during
infections and is produced by nearly every type of
cell in the immune system.25,26 IL-10 is known to
decrease the synthesis of pro-inflammatory cyto-
kines in acute phase response as IL-1α, IL-1β,
IL-6, and TNF-α by neutrophils.27 In mouse lung
fibroblast exposed to mechanical stretch, IL-10
inhibited inflammatory cytokines.25 Low lung
concentrations of IL-10 in patients with acute
lung injury is an indication for development of
adult respiratory distress syndrome.28 Adminis-
tration of IL-10 has shown protective effects in
LPS-induced lung injury.29 Interestingly, inhaled
IL-10 attenuates biotrauma and mortality in a
ventilator-induced lung injury model in rats.30
We did not observe an attenuation of pro-
inflammatory cytokine levels, pulmonary
ICAM-1 levels, or pulmonary neutrophil influx.
A possible explanation for this could be that
although IL-10 is known to attenuate inflamma-
tion, the acute phase response in our MVmodel is
only a mild inflammatory response.
We did not include an unventilated group,
whereas the placement of an indwelling tail cath-
eter in an awake mouse provides extreme stress
which could lead to false high cytokine levels.
Furthermore, previous investigations have shown
that cytokine levels of unventilated mice are
below or extremely close to detection limits.21–23
Dosage of lidocaine, especially 8 mg/kg/h, is rela-
tively high. In comparison, dosages of 2 mg/kg/h
can be considered safe in humans, 4 mg/kg/h is
relatively high, and 8 mg/kg/h is considered too
high in humans.31 Previous research has shown
an ED50 for central nervous system and cardiac
toxicity in mice of approximately 19.5 mg/kg and
S. VAN DER WAL ET AL.
Acta Anaesthesiologica Scandinavica 59 (2015) 47–55
© 2014 The Acta Anaesthesiologica Scandinavica Foundation. Published by John Wiley & Sons Ltd50
21.2 mg/kg.32 The cardiac side effects of lidocaine,
contributed by the blockage of voltage-gated
sodium channels, appear at plasma levels higher
than 10 μg/ml in humans.33 Considering the high
ED50 for lidocaine in mice and extensive animal
research in lidocaine toxicity with similar dosage,
we did not measure plasma levels of lidocaine,
and we have strong indications we stayed under
critical plasma levels of lidocaine. One mouse
however died in the 8 mg/kg/h group, because of
uncontrollable hypotension, which could possi-
bly indicate an overdose of lidocaine. In lung
homogenates, a significant increase of IL-10 was
observed only at 8 mg/kg/h lidocaine (Lido 8),
suggesting a possible dose-related effect. Mice in
our experiment showed a decrease in anesthetic
need with lidocaine administration which is con-
sistent with previous experiments.16,17 Although a
decreased anesthetic need did not lead to an
attenuation of other cytokine levels in our experi-
ment, an influence on the level of IL-10 cannot
completely be ruled out.
Fig. 1. Cytokine levels in plasma. Levels of interleukin (IL)-1β, IL-6, IL-10, tumor necrosis factor (TNF)-α, and keratinocyte derived chemokine (KC) in
ventilated control (CON) compared with ventilated lidocaine mice (Lido) receiving lidocaine in different dosages. Lidocaine was given in dosages of
2 mg/kg/h, 4 mg/kg/h, and 8 mg/kg/h. (Panels A–E). Lido 2,4, and 8 showed increased IL-10 compared with CON. No differences were observed within
the different ventilated groups of IL-1β, IL-6, IL-10, TNF-α, and KC. Data are expressed as median with interquartile range (IQR). (*P < 0.05)
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In conclusion, low-dose intravenously admin-
istered lidocaine in MV increases levels of
plasma IL-10 with infusion from 2 mg/kg/h,
4 mg/kg/h, and 8 mg/kg/h and pulmonary levels
of IL-10 with 8 mg/kg/h, in a murine mechanical
ventilation model indicating a modulatory role of
lidocaine in inflammatory response. After 4 h of
MV, no effects were found on pro-inflammatory
cytokines, neutrophil influx, or ICAM-1 levels.
More research has to be performed to elucidate
the exact role of lidocaine in ventilator-induced
pulmonary inflammation and cytokine levels
during time, and since we only ventilated mice
for 4 h, the full impact of lidocaine on the
MV-induced inflammatory response, cannot be
fully described.
Lidocaine could prove to be an interesting
therapeutic in multiple hit models. Furthermore,
Fig. 2. Cytokine levels in lung homogenates. Levels of interleukin (IL)-1β, IL-6, IL-10, tumor necrosis factor (TNF)-α, keratinocyte derived chemokine
(KC), and IL-1α in ventilated control (CON) compared with ventilated lidocaine mice (Lido) receiving lidocaine in different dosages. Lidocaine was given
in dosages of 2 mg/kg/h, 4 mg/kg/h, and 8 mg/kg/h. (Panels A–F). Lido 8 showed increased IL-10 compared with CON. No differences were observed
within the different ventilated groups of IL-1β, IL-6, IL-10, TNF-α, KC, and IL-1α. Data are expressed as median with interquartile range (IQR).
(*P < 0.05)
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intravenously administered lidocaine decreases
anesthetic need.
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